Case Report
BibTex RIS Cite

Year 2025, Volume: 42 Issue: 3, 349 - 355, 30.09.2025

Abstract

References

  • Lee SJ, Flowers ME. Recognizing and managing chronic graft-versus-host disease. ASH Education Program Book. 2008;2008(1):134-41.
  • Tollemar V, Garming Legert K, Sugars RV. Perspectives on oral chronic graft-versus-host disease from immunobiology to morbid diagnoses. Frontiers in Immunology. 2023;14:1151493.
  • Li D, Shan Y, Sun W, Wang X, Duo L. Multiple Oral Manifestations in a Patient With Chronic Graft Versus Host Disease: A Case Report. Cureus. 2024;16(9).
  • Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group report. Biology of Blood and Marrow Transplantation. 2015;21(3):389-401. e1.
  • Lazaryan A, Arora M. Evolving concepts in prognostic scoring of chronic GvHD. Bone marrow transplantation. 2017;52(10):1361-6.
  • Pavletic SZ, Martin PJ, Schultz KR, Lee SJ. The future of chronic graft-versus-host disease: introduction to the 2020 National Institutes of Health Consensus Development Project reports. Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy. 2021;27(6):448-51.
  • Couriel D, Carpenter PA, Cutler C, Bolaños-Meade J, Treister NS, Gea-Banacloche J, et al. Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biology of Blood and Marrow Transplantation. 2006;12(4):375-96.
  • Kariminia A, Holtan SG, Ivison S, Rozmus J, Hebert M-J, Martin PJ, et al. Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells. Blood, The Journal of the American Society of Hematology. 2016;127(24):3082-91.
  • Qiu X, Yu T, Xu Y. A Rare Case of Tongue Neoplasia Treated Successfully in a Patient With B-Cell Acute Lymphoblastic Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation. Journal of Craniofacial Surgery. 2021;32(5):e452-e4.
  • Hashimoto K, Nagao T, Koie S, Miyabe S, Saito T. Secondary squamous cell carcinoma of the tongue complicated with bronchiolitis obliterans as a manifestation of graft‐versus‐host disease following peripheral blood stem cell transplantation. Case Reports in Hematology. 2019;2019(1):6015803.
  • Kaffenberger BH, Huff SB, Vasu S. Epitope spread in chronic mucosal GVHD: mucous membrane pemphigoid resolution with rituximab. International Journal of Dermatology. 2019;58(2).
  • Kaya H, Okumura H, Ishizawa S. Improvement of chronic GVHD after oral treatment with Clostridium butyricum (Miya BM). Anaerobe. 2022;76:102612.
  • Spałek A, Grygoruk-Wiśniowska I, Gruenpeter K, Panz-Klapuch M, Helbig G. Spectacular and Prompt Response to Extracorporeal Photopheresis for Refractory Cutaneous Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report. Medicina. 2022;58(12):1722.
  • Wu T, Liu Z, Yong X, Mei G, Jiang Q, Fang M, et al. P16-positive secondary tongue squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: A case report and literature review. Oral Oncology. 2021;121:105399.
  • Woelfinger P, Hauptrock B, Kriege O, Wagner W, Heider J, Schwarting A, et al., editors. Alloimmune Myositis as Paraneoplastic Complication of an Oral Squamous Cell Carcinoma After Severe Chronic Graft vs Host Disease or a Manifestation of Chronic Graft vs Host Disease? A Case Report and Literature Discussion. Transplantation Proceedings; 2021: Elsevier.
  • Epstein JB, Raber-Durlacher JE, Epstein GL, Hazenberg MD, Tzachanis D, Spielberger RT. Chronic oral graft-versus- host disease: induction and maintenance therapy with photobiomodulation therapy. Supportive Care in Cancer. 2021;29:1387-94.
  • Liu Y, Yuan W, Li M, Cheng L, Yang J, Yin B, et al. In situ buccal carcinoma in a teenager after hematopoietic stem cell transplantation: A case report. Medicine. 2020;99(43):e22781.
  • Campos L, Rezende SB, Simoes A, Palma LF, Tateno RY, da Silva RL, et al. Photobiomodulation and photodynamic therapy for the management of oral graft-versus-host disease: A case report. Photodiagnosis and Photodynamic Therapy. 2020;30:101776.
  • Teoh CS, Goh AS. Relapsed chronic lymphocytic leukaemia with concomitant extensive chronic Graft versus host disease after allogeneic haematopoietic stem cell transplantation successfully treated with oral venetoclax. Case reports in transplantation. 2021;2021(1):8831125.
  • Leidens N, Ballardin BS, Leal GA, de Araújo AMM, Sessenta‐Junior CF, Torres‐Pereira CC, et al. Graft‐versus‐host disease and herpes simplex virus oral injuries in onco‐hematological patient: Case report. Special Care in Dentistry. 2022;42(1).
  • Rezende SB, Campos L, Palma LF, Tateno RY, Simões A, Macedo MC, et al. Antimicrobial photodynamic therapy for recurrent herpes labialis in chronic graft‐versus‐host disease: A case report. Photodermatology, Photoimmunology & Photomedicine. 2021;37(4).
  • Liu Z, Peng Y, Yong X, Mei G, Yang Y, Yi C, et al. A case report of secondary oral squamous cell carcinoma after allogeneic hematopoietic stem cell transplantation. Oral oncology. 2020;109:104629.

Oral manifestations of chronic graft-versus-host disease in leukemia patients: A case Series and brief literature review

Year 2025, Volume: 42 Issue: 3, 349 - 355, 30.09.2025

Abstract

Chronic graft-versus-host disease (cGVHD) is a common complication following allogeneic hematopoietic cell transplantation, frequently involves the oral cavity and may present as the initial manifestation. This study included three cases of oral cGVHD in patients (one woman and two men aged 53, 57, and 43) who underwent hematopoietic cell transplantation for leukemia, along with a brief literature review. The patients predominantly exhibited oral manifestations, including lichen-like lesions, erythema, and ulcerations. Additionally, one case presented with hyperpigmentation, while another developed chronic hyperplastic candidiasis. This study aims to present the oral findings of three cases of oral cGVHD and to analyze relevant cases reported in previous research for comparison.

Ethical Statement

Informed consent: Informed consent was obtained to confirm patients’ permission.

References

  • Lee SJ, Flowers ME. Recognizing and managing chronic graft-versus-host disease. ASH Education Program Book. 2008;2008(1):134-41.
  • Tollemar V, Garming Legert K, Sugars RV. Perspectives on oral chronic graft-versus-host disease from immunobiology to morbid diagnoses. Frontiers in Immunology. 2023;14:1151493.
  • Li D, Shan Y, Sun W, Wang X, Duo L. Multiple Oral Manifestations in a Patient With Chronic Graft Versus Host Disease: A Case Report. Cureus. 2024;16(9).
  • Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group report. Biology of Blood and Marrow Transplantation. 2015;21(3):389-401. e1.
  • Lazaryan A, Arora M. Evolving concepts in prognostic scoring of chronic GvHD. Bone marrow transplantation. 2017;52(10):1361-6.
  • Pavletic SZ, Martin PJ, Schultz KR, Lee SJ. The future of chronic graft-versus-host disease: introduction to the 2020 National Institutes of Health Consensus Development Project reports. Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy. 2021;27(6):448-51.
  • Couriel D, Carpenter PA, Cutler C, Bolaños-Meade J, Treister NS, Gea-Banacloche J, et al. Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biology of Blood and Marrow Transplantation. 2006;12(4):375-96.
  • Kariminia A, Holtan SG, Ivison S, Rozmus J, Hebert M-J, Martin PJ, et al. Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells. Blood, The Journal of the American Society of Hematology. 2016;127(24):3082-91.
  • Qiu X, Yu T, Xu Y. A Rare Case of Tongue Neoplasia Treated Successfully in a Patient With B-Cell Acute Lymphoblastic Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation. Journal of Craniofacial Surgery. 2021;32(5):e452-e4.
  • Hashimoto K, Nagao T, Koie S, Miyabe S, Saito T. Secondary squamous cell carcinoma of the tongue complicated with bronchiolitis obliterans as a manifestation of graft‐versus‐host disease following peripheral blood stem cell transplantation. Case Reports in Hematology. 2019;2019(1):6015803.
  • Kaffenberger BH, Huff SB, Vasu S. Epitope spread in chronic mucosal GVHD: mucous membrane pemphigoid resolution with rituximab. International Journal of Dermatology. 2019;58(2).
  • Kaya H, Okumura H, Ishizawa S. Improvement of chronic GVHD after oral treatment with Clostridium butyricum (Miya BM). Anaerobe. 2022;76:102612.
  • Spałek A, Grygoruk-Wiśniowska I, Gruenpeter K, Panz-Klapuch M, Helbig G. Spectacular and Prompt Response to Extracorporeal Photopheresis for Refractory Cutaneous Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report. Medicina. 2022;58(12):1722.
  • Wu T, Liu Z, Yong X, Mei G, Jiang Q, Fang M, et al. P16-positive secondary tongue squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: A case report and literature review. Oral Oncology. 2021;121:105399.
  • Woelfinger P, Hauptrock B, Kriege O, Wagner W, Heider J, Schwarting A, et al., editors. Alloimmune Myositis as Paraneoplastic Complication of an Oral Squamous Cell Carcinoma After Severe Chronic Graft vs Host Disease or a Manifestation of Chronic Graft vs Host Disease? A Case Report and Literature Discussion. Transplantation Proceedings; 2021: Elsevier.
  • Epstein JB, Raber-Durlacher JE, Epstein GL, Hazenberg MD, Tzachanis D, Spielberger RT. Chronic oral graft-versus- host disease: induction and maintenance therapy with photobiomodulation therapy. Supportive Care in Cancer. 2021;29:1387-94.
  • Liu Y, Yuan W, Li M, Cheng L, Yang J, Yin B, et al. In situ buccal carcinoma in a teenager after hematopoietic stem cell transplantation: A case report. Medicine. 2020;99(43):e22781.
  • Campos L, Rezende SB, Simoes A, Palma LF, Tateno RY, da Silva RL, et al. Photobiomodulation and photodynamic therapy for the management of oral graft-versus-host disease: A case report. Photodiagnosis and Photodynamic Therapy. 2020;30:101776.
  • Teoh CS, Goh AS. Relapsed chronic lymphocytic leukaemia with concomitant extensive chronic Graft versus host disease after allogeneic haematopoietic stem cell transplantation successfully treated with oral venetoclax. Case reports in transplantation. 2021;2021(1):8831125.
  • Leidens N, Ballardin BS, Leal GA, de Araújo AMM, Sessenta‐Junior CF, Torres‐Pereira CC, et al. Graft‐versus‐host disease and herpes simplex virus oral injuries in onco‐hematological patient: Case report. Special Care in Dentistry. 2022;42(1).
  • Rezende SB, Campos L, Palma LF, Tateno RY, Simões A, Macedo MC, et al. Antimicrobial photodynamic therapy for recurrent herpes labialis in chronic graft‐versus‐host disease: A case report. Photodermatology, Photoimmunology & Photomedicine. 2021;37(4).
  • Liu Z, Peng Y, Yong X, Mei G, Yang Y, Yi C, et al. A case report of secondary oral squamous cell carcinoma after allogeneic hematopoietic stem cell transplantation. Oral oncology. 2020;109:104629.
There are 22 citations in total.

Details

Primary Language English
Subjects Transplantation Immunology
Journal Section Case Report
Authors

Nilüfer Gürsoy 0000-0001-5056-7679

Elif Çelebi 0000-0001-7823-9562

İrfan Sarıca 0000-0003-1038-8275

Publication Date September 30, 2025
Submission Date March 11, 2025
Acceptance Date August 29, 2025
Published in Issue Year 2025 Volume: 42 Issue: 3

Cite

APA Gürsoy, N., Çelebi, E., & Sarıca, İ. (2025). Oral manifestations of chronic graft-versus-host disease in leukemia patients: A case Series and brief literature review. Deneysel Ve Klinik Tıp Dergisi, 42(3), 349-355.
AMA Gürsoy N, Çelebi E, Sarıca İ. Oral manifestations of chronic graft-versus-host disease in leukemia patients: A case Series and brief literature review. J. Exp. Clin. Med. September 2025;42(3):349-355.
Chicago Gürsoy, Nilüfer, Elif Çelebi, and İrfan Sarıca. “Oral Manifestations of Chronic Graft-versus-Host Disease in Leukemia Patients: A Case Series and Brief Literature Review”. Deneysel Ve Klinik Tıp Dergisi 42, no. 3 (September 2025): 349-55.
EndNote Gürsoy N, Çelebi E, Sarıca İ (September 1, 2025) Oral manifestations of chronic graft-versus-host disease in leukemia patients: A case Series and brief literature review. Deneysel ve Klinik Tıp Dergisi 42 3 349–355.
IEEE N. Gürsoy, E. Çelebi, and İ. Sarıca, “Oral manifestations of chronic graft-versus-host disease in leukemia patients: A case Series and brief literature review”, J. Exp. Clin. Med., vol. 42, no. 3, pp. 349–355, 2025.
ISNAD Gürsoy, Nilüfer et al. “Oral Manifestations of Chronic Graft-versus-Host Disease in Leukemia Patients: A Case Series and Brief Literature Review”. Deneysel ve Klinik Tıp Dergisi 42/3 (September2025), 349-355.
JAMA Gürsoy N, Çelebi E, Sarıca İ. Oral manifestations of chronic graft-versus-host disease in leukemia patients: A case Series and brief literature review. J. Exp. Clin. Med. 2025;42:349–355.
MLA Gürsoy, Nilüfer et al. “Oral Manifestations of Chronic Graft-versus-Host Disease in Leukemia Patients: A Case Series and Brief Literature Review”. Deneysel Ve Klinik Tıp Dergisi, vol. 42, no. 3, 2025, pp. 349-55.
Vancouver Gürsoy N, Çelebi E, Sarıca İ. Oral manifestations of chronic graft-versus-host disease in leukemia patients: A case Series and brief literature review. J. Exp. Clin. Med. 2025;42(3):349-55.